Publications

Journal Article
Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.
Ppublish 561 citations
Electronic publication date
September 2, 2016

View on Pubmed.gov 26976580 | View on doi.org 10.1073/pnas.15...

Identification of tissue-specific cell death using methylation patterns of circulating DNA.

Search for publications in this journal Proc Natl Acad Sci U S A - 113(13):E1826-34

Abstract

Minimally invasive detection of cell death could prove an invaluable resource in many physiologic and pathologic situations. Cell-free circulating DNA (cfDNA) released from dying cells is emerging as a diagnostic tool for monitoring cancer dynamics and graft failure. However, existing methods rely on differences in DNA sequences in source tissues, so that cell death cannot be identified in tissues with a normal genome. We developed a method of detecting tissue-specific cell death in humans based on tissue-specific methylation patterns in cfDNA. We interrogated tissue-specific methylome databases to identify cell type-specific DNA methylation signatures and developed a method to detect these signatures in mixed DNA samples. We isolated cfDNA from plasma or serum of donors, treated the cfDNA with bisulfite, PCR-amplified the cfDNA, and sequenced it to quantify cfDNA carrying the methylation markers of the cell type of interest. Pancreatic β-cell DNA was identified in the circulation of patients with recently diagnosed type-1 diabetes and islet-graft recipients; oligodendrocyte DNA was identified in patients with relapsing multiple sclerosis; neuronal/glial DNA was identified in patients after traumatic brain injury or cardiac arrest; and exocrine pancreas DNA was identified in patients with pancreatic cancer or pancreatitis. This proof-of-concept study demonstrates that the tissue origins of cfDNA and thus the rate of death of specific cell types can be determined in humans. The approach can be adapted to identify cfDNA derived from any cell type in the body, offering a minimally invasive window for diagnosing and monitoring a broad spectrum of human pathologies as well as providing a better understanding of normal tissue dynamics.

References

Transplantation. 2013 Jul 15;96(1):97-101

Resuscitation. 2013 Mar;84(3):351-6

Sci Transl Med. 2014 Feb 19;6(224):224ra24

Nat Rev Cancer. 2011 Jun;11(6):426-37

Cited by 561 citations (total)

Journal Article Review

Circulating cell-free DNA for cancer early detection.

Electronic publication date June 2, 2022

Search for publications in this journal Innovation (Camb)

Qiang Gao [...] Jia Fan et al.

Effective screening modalities are currently available for only a small subset of cancers, and they generally have suboptimal performance with...

Clinical Trial Journal Article

Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive Impairment.

Electronic publication date July 1, 2017

Search for publications in this journal PLoS One

Nobuyuki Kobayashi [...] Kazuhiro Kondo et al.

In order to conduct early therapeutic interventions for Alzheimer's disease (AD), convenient, early diagnosis markers are required. We previously reported...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances